ˈɛmɚɹi jˌuːnɪvˈɜːsᵻɾi sˈoʊld ɪts ɹˈɔɪəlɾiz ɔnðə dɹˈʌɡ tə ɹˈɔɪəlɾi fˈɑːɹmə ænd ɡˈɪliˌæd sˈaɪənsᵻz ɪn dʒuːlˈaɪ tˈuː θˈaʊzənd fˈaɪv fɔːɹ dˈɑːlɚ fˈaɪvhˈʌndɹɪd twˈɛnti fˈaɪv mˈɪliən.
Emory University sold its royalties on the drug to Royalty Pharma and Gilead Sciences in July 2005 for $525 million.